As of Jun 24
| -0.0616 / -5.98%|
The 3 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +519.58% increase from the last price of 0.97.
The current consensus among 3 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.